Get the Stockscreener App
22.09
3.66%
0.78
Overview
News
Price History
Option Chain
Financials
Why TEVA Down?
Discussions
Forecast
Stock Split
Dividend History
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Forecast
The Teva Pharmaceutical Industries Ltd Adr (TEVA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.2963, representing a -57.92% decrease from the current price of $22.09. The highest analyst price target is $9.9112, and the lowest is $8.6813.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TEVA Price Target
Average 9.6266
(-56.42% Downside)
Is Teva Pharmaceutical Industries Ltd Adr (TEVA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 78.06 | Sell |
| STOCH(9,6) | 65.89 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.8879 | Buy |
| ADX(14) | 30.56 | Buy |
| William %R | -1.3514 | Sell |
| CCI(14) | 174.42 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
18.77
Buy
|
19.46
Buy
|
| MA20 |
17.93
Buy
|
18.53
Buy
|
| MA50 |
17.80
Buy
|
17.94
Buy
|
| MA100 |
17.82
Buy
|
17.53
Buy
|
| MA200 |
16.63
Buy
|
16.20
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, TEVA could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on TEVA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 78.06 indicates that TEVA is overbought. This suggests that TEVA price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 65.89 indicates that TEVA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that TEVA is oversold. This suggests that TEVA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.56 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 174.42 indicates that TEVA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term TEVA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Teva Pharmaceutical Industries Ltd Adr financial reports and earnings history, Teva Pharmaceutical Industries Ltd Adr (TEVA) stock could reach $12.34 by 2030, $8.4836 by 2040 and $6.3879 by 2050. See the projected annual prices until 2050 of the Teva Pharmaceutical Industries Ltd Adr stock below:
- Teva Pharmaceutical Industries Ltd Adr (TEVA) is expected to reach an average price of $8.8082 in 2035, with a high prediction of $8.8782 and a low estimate of $7.4829. This indicates an $-60.13% rise from the last recorded price of $22.09.
- Teva Pharmaceutical Industries Ltd Adr (TEVA) stock is projected to chart a bullish course in 2040, with an average price target of $7.6138, representing an $-65.53% surge from its current level. The forecast ranges from a conservative $6.9836 to a sky-high $8.4836.
- Our analysts predict Teva Pharmaceutical Industries Ltd Adr (TEVA) to jump -68.46% by 2045, soaring from $6.1471 to an average price of $6.9672, potentially reaching $7.9268. While $6.1471 is the low estimate, the potential upside is significant.
- Teva Pharmaceutical Industries Ltd Adr (TEVA) stock is expected to climb by 2050, reaching an average of $6.0184, a $-72.76% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.3879 and $5.3684, respectively, highlighting the market's uncertainty.
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Year by Year Forecast
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Price Forecast for 2025
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) is expected to reach an average price of $9.6266 in 2025, with a high prediction of $13.38 and a low estimate of $5.8717. This indicates an -56.42% fall from the last recorded price of $22.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $8.6963 | $8.6813 | $9.9112 | -60.63% |
| February, 2025 | $9.9464 | $8.3864 | $10.74 | -54.97% |
| March, 2025 | $10.97 | $10.12 | $13.38 | -50.36% |
| April, 2025 | $8.5467 | $5.8717 | $11.64 | -61.31% |
| May, 2025 | $9.9919 | $7.5718 | $10.28 | -54.77% |
| June, 2025 | $10.83 | $9.342 | $11.67 | -50.96% |
| July, 2025 | $12.30 | $10.50 | $12.85 | -44.31% |
| August, 2025 | $11.38 | $10.73 | $12.80 | -48.47% |
| September, 2025 | $11.54 | $10.81 | $12.44 | -47.75% |
| October, 2025 | $8.8126 | $8.4226 | $11.68 | -60.11% |
| November, 2025 | $8.6328 | $8.0827 | $9.1327 | -60.92% |
| December, 2025 | $8.3429 | $8.0829 | $9.7128 | -62.23% |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Price Forecast for 2026
The predicted value for Teva Pharmaceutical Industries Ltd Adr (TEVA) in 2026 is set at an average of $10.39. Estimates vary from a peak of $12.92 to a trough of $7.8643, indicating an -52.95% surge from the present price of $22.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.4431 | $8.063 | $9.5081 | -57.25% |
| February, 2026 | $9.6332 | $8.8831 | $10.69 | -56.39% |
| March, 2026 | $11.59 | $9.0533 | $11.68 | -47.52% |
| April, 2026 | $10.66 | $10.53 | $12.92 | -51.73% |
| May, 2026 | $11.14 | $9.8136 | $11.46 | -49.55% |
| June, 2026 | $10.66 | $10.48 | $11.61 | -51.73% |
| July, 2026 | $10.19 | $9.564 | $10.74 | -53.85% |
| August, 2026 | $10.73 | $9.979 | $11.17 | -51.41% |
| September, 2026 | $8.9243 | $8.6743 | $10.82 | -59.60% |
| October, 2026 | $9.6394 | $7.8643 | $9.9594 | -56.36% |
| November, 2026 | $9.0445 | $8.5745 | $9.8344 | -59.06% |
| December, 2026 | $9.3647 | $8.2147 | $9.6247 | -57.61% |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Teva Pharmaceutical Industries Ltd Adr (TEVA) is $8.686, with a high forecast of $10.97 and a low forecast of $6.4055. This indicates an -60.68% decrease from the last price of $22.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.7349 | $9.0898 | $9.9048 | -55.93% |
| February, 2027 | $8.505 | $8.1749 | $9.8849 | -61.50% |
| March, 2027 | $7.8252 | $7.5651 | $8.555 | -64.58% |
| April, 2027 | $8.7953 | $7.3552 | $9.0003 | -60.18% |
| May, 2027 | $8.1354 | $7.6754 | $8.7553 | -63.17% |
| June, 2027 | $7.0856 | $7.0156 | $8.9555 | -67.92% |
| July, 2027 | $9.0157 | $6.8657 | $9.1857 | -59.19% |
| August, 2027 | $8.7459 | $8.6159 | $10.13 | -60.41% |
| September, 2027 | $8.6661 | $6.856 | $8.8361 | -60.77% |
| October, 2027 | $7.3362 | $7.1587 | $9.1461 | -66.79% |
| November, 2027 | $7.0663 | $7.0163 | $7.9913 | -68.01% |
| December, 2027 | $10.84 | $6.4055 | $10.97 | -50.94% |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Price Forecast for 2028
In 2028, Teva Pharmaceutical Industries Ltd Adr (TEVA) is projected to reach an average price of $8.8927, with a high projection of $11.07 and a low estimate of $6.7131. This indicates an -59.74% fall from the last price of $22.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.4666 | $8.2666 | $10.90 | -61.67% |
| February, 2028 | $7.6968 | $7.2668 | $9.0467 | -65.16% |
| March, 2028 | $8.5469 | $7.4668 | $8.6269 | -61.31% |
| April, 2028 | $8.4971 | $7.577 | $9.267 | -61.53% |
| May, 2028 | $8.8673 | $7.8672 | $9.0423 | -59.86% |
| June, 2028 | $10.04 | $8.6273 | $11.07 | -54.56% |
| July, 2028 | $9.8875 | $9.3525 | $10.59 | -55.24% |
| August, 2028 | $8.7477 | $8.7077 | $10.03 | -60.40% |
| September, 2028 | $8.8978 | $7.8978 | $8.9678 | -59.72% |
| October, 2028 | $8.398 | $7.7279 | $9.2279 | -61.98% |
| November, 2028 | $6.8581 | $6.7131 | $8.838 | -68.95% |
| December, 2028 | $7.1583 | $6.7682 | $7.3833 | -67.59% |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Price Forecast for 2029
The 2029 price forecast for Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) is $10.81 on average, with a high prediction of $14.58 and a low estimate of $7.0483. This represents an -51.05% decrease from the previous price of $22.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.0284 | $7.0483 | $8.3784 | -63.66% |
| February, 2029 | $9.3286 | $7.8385 | $9.6235 | -57.77% |
| March, 2029 | $10.22 | $8.8887 | $10.29 | -53.74% |
| April, 2029 | $8.2889 | $8.1139 | $10.35 | -62.48% |
| May, 2029 | $8.309 | $7.6839 | $9.1985 | -62.39% |
| June, 2029 | $9.3392 | $8.1791 | $9.6991 | -57.72% |
| July, 2029 | $10.07 | $8.9792 | $10.33 | -54.42% |
| August, 2029 | $11.73 | $10.08 | $12.27 | -46.90% |
| September, 2029 | $12.52 | $11.46 | $12.98 | -43.32% |
| October, 2029 | $13.52 | $12.63 | $13.60 | -38.80% |
| November, 2029 | $12.49 | $12.14 | $14.09 | -43.46% |
| December, 2029 | $13.60 | $12.32 | $14.58 | -38.43% |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Price Forecast for 2030
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) is expected to reach an average price of $9.157 in 2030, with a high forecast of $13.00 and a low forecast of $5.311. This signifies an -58.55% decrease from the last price of $22.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.4853 | $7.4303 | $12.34 | -66.11% |
| February, 2030 | $8.4856 | $7.2004 | $9.2705 | -61.59% |
| March, 2030 | $7.0909 | $6.7208 | $8.5607 | -67.90% |
| April, 2030 | $6.1062 | $5.311 | $7.231 | -72.36% |
| May, 2030 | $6.1365 | $5.6312 | $7.7296 | -72.22% |
| June, 2030 | $7.3118 | $5.6816 | $8.1918 | -66.90% |
| July, 2030 | $9.4621 | $7.2718 | $10.03 | -57.17% |
| August, 2030 | $9.3374 | $8.6223 | $10.23 | -57.73% |
| September, 2030 | $8.2377 | $8.1227 | $9.5325 | -62.71% |
| October, 2030 | $11.42 | $8.0077 | $13.00 | -48.31% |
| November, 2030 | $7.3183 | $6.5433 | $12.80 | -66.87% |
| December, 2030 | $7.5816 | $5.4934 | $8.6735 | -65.68% |
3.22%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):